Clinical Trial Update: Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A randomized Phase II trial comparing Epirubicin versus Caelyx in pretreated metastatic breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Caelyx (liposomal doxorubicin)
• Epirubicin (epirubicin)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED